Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
K2bio logo — Enhance your research...

K2bio

Enhance your research...

Founded 2021 United States Houston, United States 14 employees Seed Total: $615.52K Biotechnology, Health Care

General Information

Company Name K2bio
Founded Year 2021
Location United States Houston, United States
Employees 14
Industries Biotechnology, Health Care
Funding Stage Seed
Business Model B2B, B2D
Revenue Model Service Fee, Usage Based, Project Based
Social

BounceWatch is an independent company data service, not affiliated with K2bio. To contact K2bio, visit k2-biolabs.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does K2bio compare?

A PDF of K2bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting K2bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About K2bio

K2bio, founded in 2021, is a dynamic player in the Biotechnology and Health Care sectors, operating out of the United States. The company specializes as a Preclinical Contract Research Organization (CRO) based in Houston, Texas, and is specifically tailored for pharmaceutical product research. With a commitment to delivering full support for in vivo and in vitro testing and ensuring regulatory compliance, K2bio’s approach involves providing customized solutions to offer precise and valuable data to its clients.

Amidst the challenging backdrop of global health care research, K2bio secured a $615.52K Seed Round in investment on 01 August 2023. This recent funding signals an endorsement of their business model from the investor community and positions them well for scaling impact in the preclinical research domain. With their slogan, "Enhance your research...", K2bio aims to be a pivotal contributor to biotechnical advancements.

Business keywords: Preclinical Contract Research Organization, CRO, In Vivo Support, In Vitro Support, Regulatory Oversight, Pharmaceutical Products, Customized Solutions, Life Sciences, Drug Development, Innovative Therapies, Early-Stage Life Science Companies, Analytical Development, Vivarium Management

Services & Products

In Vivo Study Design and Execution
Laboratory Space Rental
Technical Support and Infrastructure
Collaborative Research Solutions

Target Customers

Biotech Companies Pharmaceutical Partners Research Teams

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $615.52K -
01 Aug 2023

K2bio Alternatives & Competitors

K2bio vs
Novum Pharmaceutical Research Services
Novum Pharmaceutical Research Services United States

A Full-Service Global CRO with 50 Years of Excellence, Proudly Part of Lambda Therapeutic Research.

236 employees
Biotechnology, Health Care
K2bio vs
Quantigen Biosciences
Quantigen Biosciences United States

Biosciences

32 employees
Biotechnology, Health Care
K2bio vs
Global Clinical Trials (GCT)
Global Clinical Trials (GCT) United States

Global CRO, local expertise

114 employees
Biotechnology, Health Care

FAQ About K2bio

Enhance your research...
K2bio was founded in 2021.
K2bio is headquartered in Houston, United States.
K2bio operates in Biotechnology and Health Care. Its work centres on Preclinical Contract Research Organization, CRO, In Vivo Support and In Vitro Support. Its customers include Biotech Companies, Pharmaceutical Partners and Research Teams.
K2bio has a B2B and B2D business model. Its revenue comes from Service Fee, Usage Based and Project Based.
K2bio has approximately 14 employees.
K2bio has completed 1 funding round, raising a total of $615.52K. The latest funding stage is Seed.
K2bio offers: In Vivo Study Design and Execution, Laboratory Space Rental, Technical Support and Infrastructure, Collaborative Research Solutions.
Top alternatives and competitors to K2bio include Novum Pharmaceutical Research Services, Quantigen Biosciences, Global Clinical Trials (GCT), Nilogen Oncosystems, Invitrocue. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
K2bio and Novum Pharmaceutical Research Services are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for K2bio, https://bouncewatch.com/company/k2bio, updated 24 March 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes